AT&T (T)
(Delayed Data from NYSE)
$20.57 USD
+0.14 (0.69%)
Updated Sep 4, 2024 04:02 PM ET
After-Market: $20.58 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$20.57 USD
+0.14 (0.69%)
Updated Sep 4, 2024 04:02 PM ET
After-Market: $20.58 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth F Momentum C VGM
Zacks News
Company News for Apr 25, 2024
by Zacks Equity Research
Companies in The News Are: T,TMO,GD,ETR
AT&T (T) Q1 Earnings Beat Estimates, Revenues Remain Flat Y/Y
by Zacks Equity Research
AT&T (T) surpasses first-quarter earnings estimates, backed by healthy 5G and fiber customer additions and strong cash flow.
AT&T (T) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for AT&T (T) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
AT&T (T) vs. T-Mobile (TMUS): Which Stock Wins in Q1 Earnings?
by Zacks Equity Research
TMUS appears to be a better pick now compared to T, given the solid EPS growth in recent quarters, greater 5G coverage and robust demand for postpaid services.
AT&T (T) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for AT&T (T), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
T-Mobile (TMUS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
T-Mobile (TMUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Modest Top-Line Improvement Aid AT&T's (T) Q1 Earnings?
by Zacks Equity Research
AT&T (T) is expected to have witnessed a top-line improvement year over year in first-quarter 2024 on healthy wireless traction, driven by steady investments for 5G expansion and fiber broadband infrastructure development.
Is iShares MSCI USA Value Factor ETF (VLUE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VLUE
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
Here's Why You Should Keep American Tower (AMT) in Your Kitty
by Zacks Equity Research
Solid demand for American Tower's (AMT) wireless communication assets by network carriers and expansion efforts bode well. However, customer concentration and high interest rates are major woes.
AT&T (T) Pledges Additional Funds to Bridge Digital Divide
by Zacks Equity Research
As the digital landscape evolves, AT&T's (T) commitment to closing the digital divide underscores its dedication to fostering inclusive connectivity and driving socio-economic progress.
Comcast's (CMCSA) Xfinity Mobile Unveils New Value Plans
by Zacks Equity Research
Comcast's (CMCSA) Xfinity Mobile unveils new unlimited plans, offering more premium data and extra features compared with major telecom providers.
The Zacks Analyst Blog Highlights Meta Platforms, S&P Global, AT&T, CME and FedEx
by Zacks Equity Research
Meta Platforms, S&P Global, AT&T, CME and FedEx are part of the Zacks top Analyst Blog.
Top Analyst Reports for Meta Platforms, S&P Global & AT&T
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), S&P Global Inc. (SPGI) and AT&T Inc. (T).
New Strong Sell Stocks for March 25th
by Zacks Equity Research
T, AGL and ALTO have been added to the Zacks Rank #5 (Strong Sell) List on March 25, 2023.
Is It Wise to Retain SBA Communications (SBAC) Stock for Now?
by Zacks Equity Research
SBA Communications (SBAC) is likely to benefit from the rising global demand for wireless connectivity and its asset buyouts. However, notable customer concentration and high interest rates are key woes.
Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SPHD
Comcast (CMCSA) Texas to Invest $1M for Digital Training
by Zacks Equity Research
Comcast (CMCSA) Texas promises to invest more than $1 million to reduce the local digital gap in 2024 by adding more Wi-Fi connected Lift Zones.
Should iShares MSCI USA Value Factor ETF (VLUE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VLUE
Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPHD
New Strong Sell Stocks for March 6th
by Zacks Equity Research
T, AMRC and AHCHY have been added to the Zacks Rank #5 (Strong Sell) List on March 6, 2023.
Zacks Investment Ideas feature highlights: Meta Platforms, AT&T, BITB, IWM and Viking Therapeutics
by Zacks Equity Research
Meta Platforms, AT&T, BITB, IWM and Viking Therapeutics are part of the Zacks Investment Ideas article.
The Zacks Analyst Blog Highlights Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic
by Zacks Equity Research
Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic are part of the Zacks top Analyst Blog.
Beyond the "Mag 7": 3 Risk-On Market Forces
by Andrew Rocco
The biggest bear argument over the past year has been the slim leadership in the market, namely concentrated in mega-cap tech stocks like the "Mag 7." However, dig deeper, and you will discover that the market is broadening quickly.
Top Analyst Reports for Eli Lilly, Procter & Gamble & Morgan Stanley
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS).